{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:56:31Z","timestamp":1787496991538,"version":"build-2736575974"},"reference-count":21,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aimed to investigate the therapeutic potential of annexin A1 (ANXA1) overexpression in improving the signs of dry eye disease (DED) and to elucidate the underlying molecular mechanism. A murine model of DED was established by topical application of 0.2% benzalkonium chloride (BAC), and human corneal epithelial (HCE-T) cells were exposed to 0.0005% BAC for\n                    <jats:italic>in vitro<\/jats:italic>\n                    experiments. ANXA1 was overexpressed using adenoviral vectors, and the effects on tear production, pyroptosis, and activation of the tripartite motif-containing protein 72 (TRIM72)\/nuclear factor erythroid 2-related factor 2 (Nrf2)\/heme oxygenase-1 (HO-1) signaling pathway were evaluated using Western blotting, Schirmer test, Terminal deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL) assays, and fluorescent probe analyses. To further examine the role of TRIM72, its expression was silenced with specific small interfering RNA (siRNA), and the consequent impact on ANXA1-mediated therapeutic effects was assessed. ANXA1 expression was significantly reduced in both\n                    <jats:italic>in vivo<\/jats:italic>\n                    and\n                    <jats:italic>in vitro<\/jats:italic>\n                    DED models. Restoration of ANXA1 through overexpression significantly improved tear secretion and suppressed pyroptosis in the murine model. Similarly, in HCE-T cells, ANXA1 overexpression not only enhanced cellular proliferation but also significantly inhibited pyroptosis. Mechanistic investigations demonstrated that ANXA1 overexpression activated the TRIM72\/Nrf2\/HO-1 signaling pathway by increasing TRIM72, Nrf2, and HO-1 expression. Notably, silencing TRIM72 abolished the therapeutic effects of ANXA1 overexpression, thereby confirming that activation of this pathway is essential for mediating the protective effects of ANXA1 against DED. Overexpression of ANXA1 inhibits pyroptosis and improves dry eye signs by regulating the TRIM72\/Nrf2\/HO-1 axis.\n                  <\/jats:p>","DOI":"10.2478\/aite-2025-0022","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:00:16Z","timestamp":1754485216000},"source":"Crossref","is-referenced-by-count":4,"title":["Overexpression of Annexin A1 Inhibits Pyroptosis and Improves Dry Eye Signs by Regulating the TRIM72\/Nrf2\/HO-1 Signaling Pathway"],"prefix":"10.2478","volume":"73","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology , Shanxi Eye Hospital Affiliated to Shanxi Medical University , Taiyuan , Shanxi , China"},{"name":"Department of Ophthalmology, Aier Eye Hospital (Taiyuan) , Taiyuan , Shanxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanxi Aier Eye Hospital (Shanxi) , Taiyuan , Shanxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanxi Aier Eye Hospital (Shanxi) , Taiyuan , Shanxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhe","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Aier Eye Hospital (Taiyuan) , Taiyuan , Shanxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology , Shanxi Eye Hospital Affiliated to Shanxi Medical University , Taiyuan , Shanxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"2026042921053591477_j_aite-2025-0022_ref_001","doi-asserted-by":"crossref","unstructured":"Casarin RCV, Salmon CR, Stolf CS et al. (2023) Salivary annexin A1: a candidate biomarker for periodontitis. J Clin Periodontol 50:942\u2013951. https:\/\/doi.org\/10.1111\/jcpe.13803","DOI":"10.1111\/jcpe.13803"},{"key":"2026042921053591477_j_aite-2025-0022_ref_002","doi-asserted-by":"crossref","unstructured":"Chen H, Gan X, Li Y et al. (2020) NLRP12- and NLRC4-mediated corneal epithelial pyroptosis is driven by GSDMD cleavage accompanied by IL-33 processing in dry eye. Ocul Surf 18:783\u2013794. https:\/\/doi.org\/10.1016\/j.jtos.2020.07.001","DOI":"10.1016\/j.jtos.2020.07.001"},{"key":"2026042921053591477_j_aite-2025-0022_ref_003","doi-asserted-by":"crossref","unstructured":"Chen M, Rong R, Xia X (2022) Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases. J Neuroinflammation 19:183. https:\/\/doi.org\/10.1186\/s12974-022-02547-2","DOI":"10.1186\/s12974-022-02547-2"},{"key":"2026042921053591477_j_aite-2025-0022_ref_004","doi-asserted-by":"crossref","unstructured":"Fernandez-Torres MA, Lled\u00f3 VE, Perez de Lara MJ et al. (2022) Effects of hyperosmolarity on annexin A1 on ocular surface epithelium in vitro. Exp Eye Res 224:109245. https:\/\/doi.org\/10.1016\/j.exer.2022.109245","DOI":"10.1016\/j.exer.2022.109245"},{"key":"2026042921053591477_j_aite-2025-0022_ref_005","doi-asserted-by":"crossref","unstructured":"Foo SL, Yap G, Cui J et al. (2019) Annexin-A1 \u2013 a blessing or a curse in cancer? Trends Mol Med 25:315\u2013327. https:\/\/doi.org\/10.1016\/j.molmed.2019.02.004","DOI":"10.1016\/j.molmed.2019.02.004"},{"key":"2026042921053591477_j_aite-2025-0022_ref_006","doi-asserted-by":"crossref","unstructured":"Hakim FE, Farooq AV (2022) Dry eye disease: an update in 2022. JAMA 327:478\u2013479. https:\/\/doi.org\/10.1001\/jama.2021.19963","DOI":"10.1001\/jama.2021.19963"},{"key":"2026042921053591477_j_aite-2025-0022_ref_007","doi-asserted-by":"crossref","unstructured":"Irie M, Kabata H, Sasahara K et al. (2023) Annexin A1 is a cell-intrinsic metalloregulator of zinc in human ILC2s. Cell Rep 42:112610. https:\/\/doi.org\/10.1016\/j.celrep.2023.112610","DOI":"10.1016\/j.celrep.2023.112610"},{"key":"2026042921053591477_j_aite-2025-0022_ref_008","doi-asserted-by":"crossref","unstructured":"Jackson CJ, Gundersen KG, Tong L et al. (2022) Dry eye disease and proteomics. Ocul Surf 24:119\u2013128. https:\/\/doi.org\/10.1016\/j.jtos.2022.03.001","DOI":"10.1016\/j.jtos.2022.03.001"},{"key":"2026042921053591477_j_aite-2025-0022_ref_009","doi-asserted-by":"crossref","unstructured":"Li S, Lu Z, Huang Y et al. (2022b) Anti-oxidative and anti-inflammatory micelles: break the dry eye vicious cycle. Adv Sci (Weinh) 9:e2200435. https:\/\/doi.org\/10.1002\/advs.202200435","DOI":"10.1002\/advs.202200435"},{"key":"2026042921053591477_j_aite-2025-0022_ref_010","doi-asserted-by":"crossref","unstructured":"Li C, Ma J, Mali N et al. (2022a) Relevance of the pyroptosis-related inflammasome drug targets in the Chuanxiong to improve diabetic nephropathy. Mol Med 28:136. https:\/\/doi.org\/10.1186\/s10020-022-00567-5","DOI":"10.1186\/s10020-022-00567-5"},{"key":"2026042921053591477_j_aite-2025-0022_ref_011","doi-asserted-by":"crossref","unstructured":"Luan Y, Luan Y, Jiao Y et al. (2023) Broadening horizons: exploring mtDAMPs as a mechanism and potential intervention target in cardiovascular diseases. Aging Dis 15:2395\u20132416. https:\/\/doi.org\/10.14336\/AD.2023.1130","DOI":"10.14336\/AD.2023.1130"},{"key":"2026042921053591477_j_aite-2025-0022_ref_012","doi-asserted-by":"crossref","unstructured":"Ren K, Pei J, Guo Y et al. (2023) Regulated necrosis pathways: a potential target for ischemic stroke. Burns Trauma 11:tkad016. https:\/\/doi.org\/10.1093\/burnst\/tkad016","DOI":"10.1093\/burnst\/tkad016"},{"key":"2026042921053591477_j_aite-2025-0022_ref_013","doi-asserted-by":"crossref","unstructured":"Safir M, Twig G, Mimouni M (2024) Dry eye disease management. BMJ 384:e077344. https:\/\/doi.org\/10.1136\/bmj-2023-077344","DOI":"10.1136\/bmj-2023-077344"},{"key":"2026042921053591477_j_aite-2025-0022_ref_014","doi-asserted-by":"crossref","unstructured":"Singh S, Basu S, Geerling G (2022) Salivary gland transplantation for dry eye disease: indications, techniques, and outcomes. Ocul Surf 26:53\u201362. https:\/\/doi.org\/10.1016\/j.jtos.2022.07.013","DOI":"10.1016\/j.jtos.2022.07.013"},{"key":"2026042921053591477_j_aite-2025-0022_ref_015","doi-asserted-by":"crossref","unstructured":"Stapleton F, Velez FG, Lau C et al. (2024) Dry eye disease in the young: a narrative review. Ocul Surf 31:11\u201320. https:\/\/doi.org\/10.1016\/j.jtos.2023.12.001","DOI":"10.1016\/j.jtos.2023.12.001"},{"key":"2026042921053591477_j_aite-2025-0022_ref_016","doi-asserted-by":"crossref","unstructured":"Wu L, Liu C, Chang DY et al. (2021) Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney Int 100:107\u2013121. https:\/\/doi.org\/10.1016\/j.kint.2021.02.025","DOI":"10.1016\/j.kint.2021.02.025"},{"key":"2026042921053591477_j_aite-2025-0022_ref_017","doi-asserted-by":"crossref","unstructured":"Xu X, Gao W, Li L et al. (2021) Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia\/macrophage polarization via FPR2\/ALX-dependent AMPK-mTOR pathway. J Neuroinflammation 18:119. https:\/\/doi.org\/10.1186\/s12974-021-02174-3","DOI":"10.1186\/s12974-021-02174-3"},{"key":"2026042921053591477_j_aite-2025-0022_ref_018","doi-asserted-by":"crossref","unstructured":"Yang H, Liu D, Wang Y (2023) Physalin A exerts neuroprotective effects: inhibition of OGD\/R-induced cellular pyroptosis and inflammatory responses in nerve cells. Signa Vitae 19:168\u2013174. https:\/\/doi.org\/10.22514\/sv.2023.111","DOI":"10.22514\/sv.2023.111"},{"key":"2026042921053591477_j_aite-2025-0022_ref_019","doi-asserted-by":"crossref","unstructured":"Yao Y, Yin Y, Shuai F et al. (2025) M2 macrophage-derived extracellular vesicles reprogram immature neutrophils into Anxa1hi neutrophils to enhance inflamed bone regeneration. Adv Sci 25:e2416159. https:\/\/doi.org\/10.1002\/advs.202416159","DOI":"10.1002\/advs.202416159"},{"key":"2026042921053591477_j_aite-2025-0022_ref_020","doi-asserted-by":"crossref","unstructured":"You Q, Ke Y, Chen X et al. (2024) Loss of endothelial annexin A1 aggravates inflammation-induched vascular aging. Adv Sci (Weinh) 11:e2307040. https:\/\/doi.org\/10.1002\/advs.202307040","DOI":"10.1002\/advs.202307040"},{"key":"2026042921053591477_j_aite-2025-0022_ref_021","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zhang L, Chen B (2025) Characterization of T cells in the progression of dry eye disease using single-cell RNA sequencing in mice. Eur J Med Res 30:338. https:\/\/doi.org\/10.1186\/s40001-025-02607-2","DOI":"10.1186\/s40001-025-02607-2"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/aite-2025-0022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:51:12Z","timestamp":1777506672000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/aite-2025-0022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,6]]},"published-print":{"date-parts":[[2025,1,1]]}},"alternative-id":["10.2478\/aite-2025-0022"],"URL":"https:\/\/doi.org\/10.2478\/aite-2025-0022","relation":{},"ISSN":["1661-4917"],"issn-type":[{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20250022"}}